Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 20, 2011

Titertek Instruments Merges with Berthold Detection Systems

  • Titertek Instruments has merged with Berthold Detection Systems to form Titertek-Berthold. The new company combines Titertek’s 35 years of producing assay-processing, liquid-handling, and detection systems with Berthold’s bio and chemiluminescence instrumentation.

    “Due to the complementary technologies, an impressive product portfolio is available but will be expanded significantly, short-term and long-term. The company is in an exceptional position to serve many life science market segments, worldwide,” Titertek-Berthold remarks.

    The combined company will continue to operate from Titertek’s 35,000 square foot facility at Cummings Research Park in Huntsville, AL, as well as from Pforzheim, Germany, where Berthold has been based. The new company says its customers are engaged in, among other activities, academic research, biotech and pharmaceutical R&D, vaccine development, food research, food quality control, human and veterinary diagnostics, diagnostic research, and quality control.

Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »